TRD_18_026-09_0004_L.jpg

Simon Nebel

Over the past 20 years, Simon was involved in 4 Private Equities vehicles in healthcare and renewable energy, as Managing Partner at Aravis, with a total of approximately CHF 250M assets under management. The funds invested in more than 25 private companies of which 19 were in healthcare. The invested start-up and growth capital has enabled the development of new diagnostics and treatments in oncology, cardiovascular, infectious and respiratory diseases. 

13 out of the 19 healthcare companies were acquired by large pharmaceutical, diagnostic or medical device companies or were listed publicly. Moreover, many of the companies have managed to strike strategic partnerships with blue chip life sciences companies such as Novartis, Roche, Boerhinger Ingelheim and AstraZeneca. 

Simon is chairman of Marinomed (Vienna), and board member of Bird Rock Bio (La Jolla) and SynAffix (Oss, Netherlands).

Simon holds a master and PhD in structural biology of the Biozentrum, University of Basel as well as an MBA with distinction of the London Business School.